Marco Di Fraia

Marco Di Fraia

Auto-generated profile, based on publicly available information

Marco Di Fraia

Division of Dermatology, Department of Internal, Anesthesiological and Cardiovascular Clinical Sciences Sapienza University Rome Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MFMarco Di Fraia
Marco Di Fraia
STSalvatore Tripodi
Salvatore Tripodi
SAStefania Arasi
Stefania Arasi
SDStephanie Dramburg
Stephanie Dramburg
SCSveva Castelli
Sveva Castelli
PMPaolo Maria Matricardi
Paolo Maria Matricardi
Background: Complete diagnosis and therapy of seasonal allergic rhinoconjunctivitis require evidence that exposure to the sensitizing pollen triggers allergic symptoms. Electronic clinical diaries, by recording disease severity scores and pollen exposure, can demonstrate this association. However, patients who spontaneously download an e-diary app show very low adherence to their recording. Objective: The objective of our study was to assess adherence of patients with seasonal allergic rhinitis to symptom recording via e-diary explicitly prescribed by an allergist within a blended care approach. Methods: The @IT-2020 project is investigating the diagnostic synergy of mobile health and molecular allergology in patients with seasonal allergic rhinitis. In the pilot phase of the study, we recruited Italian children (Rome, Italy) and adults (Pordenone, Italy) with seasonal allergic rhinitis and instructed them to record their symptoms, medication intake, and general conditions daily through a mobile app (Allergy.Monitor) during the relevant pollen season. Results: Overall, we recruited 101 Italian children (Rome) and 93 adults (Pordenone) with seasonal allergic rhinitis. Adherence to device use slowly declined during monitoring in 3 phases: phase A: first week, ≥1267/1358, 90%; phase B: second to sixth week, 4992/5884, 80% to 90%; and phase C: seventh week onward, 2063/2606, 70% to 80%. At the individual level, the adherence assessed in the second and third weeks of recording predicted with enough confidence (Rome: Spearman ρ=0.75; P<.001; Pordenone: ρ=0.81; P<.001) the overall patient adherence to recording and was inversely related to postponed reporting (ρ=–0.55; P<.001; in both centers). Recording adherence was significantly higher during the peak grass pollen season in Rome, but not in Pordenone. Conclusions: Adherence to daily recording in an e-diary, prescribed and motivated by an allergist in a blended care setting, was very high. This observation supports the use of e-diaries in addition to face-to-face visits for diagnosis and treatment of seasonal allergic rhinitis and deserves further investigation in real-life contexts.

8 June 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
ASAlvise Sernicola
Alvise Sernicola
GCG. Carnicelli
G. Carnicelli
MFM. Di Fraia
M. Di Fraia
CCC. Chello
C. Chello
CFC. Furlan
C. Furlan
Teresa GriecoTeresa Grieco
Teresa Grieco

3 June 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SDStephanie Dramburg
Stephanie Dramburg
SPSerena Perna
Serena Perna
MFMarco Di Fraia
Marco Di Fraia
STSalvatore Tripodi
Salvatore Tripodi
SAStefania Arasi
Stefania Arasi
PMPaolo Maria Matricardi
Paolo Maria Matricardi
Background: Mobile health technologies enable allergists to monitor disease trends by collecting daily patient-reported outcomes of allergic rhinitis. To this end, patients with allergies are usually required to enter their symptoms and medication repetitively over long time periods, which may present a risk to data completeness and quality in the case of insufficient effort reporting. Completeness of patient’s recording is easily measured. In contrast, the intrinsic quality and accuracy of the data entered by the patients are more elusive. Objective: The aim of this study was to explore the association of adherence to digital symptom recording with a predefined set of parameters of the patient-generated symptom and medication scores and to identify parameters that may serve as proxy measure of the quality and reliability of the information recorded by the patient. Methods: The @IT.2020 project investigates the diagnostic synergy of mobile health and molecular allergology in patients with seasonal allergic rhinitis. In its pilot phase, 101 children with seasonal allergic rhinitis were recruited in Rome and instructed to record their symptoms, medication intake, and general conditions daily via a mobile app (AllergyMonitor) during the relevant pollen season. We measured adherence to daily recording as the percentage of days with data recording in the observation period. We examined the patient’s trajectories of 3 disease indices (Rhinoconjunctivitis Total Symptom Score [RTSS], Combined Symptom and Medication Score [CSMS], and Visual Analogue Scale [VAS]) as putative proxies of data quality with the following 4 parameters: (1) intravariation index, (2) percentage of zero values, (3) coefficient of variation, and (4) percentage of changes in trend. Lastly, we examined the relationship between adherence to recording and each of the 4 proxy measures. Results: Adherence to recording ranged from 20% (11/56) to 100% (56/56), with 64.4% (65/101) and 35.6% (36/101) of the patients’ values above (highly adherent patients) or below (low adherent patients) the threshold of 80%, respectively. The percentage of zero values, the coefficient of variation, and the intravariation index did not significantly change with the adherence to recording. By contrast, the proportion of changes in trend was significantly higher among highly adherent patients, independently from the analyzed score (RTSS, CSMS, and VAS). Conclusions: The percentage of changes in the trend of RTSS, CSMS, and VAS is a valuable candidate to validate the quality and accuracy of the data recorded by patients with allergic rhinitis during the pollen season. The performance of this parameter must be further investigated in real-life conditions before it can be recommended for routine use in apps and electronic diaries devoted to the management of patients with allergic rhinitis.

23 March 2023 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
SMSimone Michelini
Simone Michelini
GCGemma Caro
Gemma Caro
MFM. Di Fraia
M. Di Fraia
MFM. Fortuna
M. Fortuna
FMF. Magri
F. Magri
GPGiovanni Pellacani
Giovanni Pellacani

1 February 2022 in Italian Journal of Dermatology and Venereology
Verified
Journal Article
Closed access
ARAlfredo Rossi
Alfredo Rossi
FMFrancesca Magri
Francesca Magri
MFMarco DI Fraia
Marco DI Fraia
GCGemma Caro
Gemma Caro
MFMaria C. Fortuna
Maria C. Fortuna
LCLeonardo Celleno
Leonardo Celleno
Article: A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study - Italian Journal of Dermatology and Venereology 2022 February;157(1):78-83 - Minerva Medica - Journals

22 April 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
IPIlaria Proietti
Ilaria Proietti
SMSimone Michelini
Simone Michelini
AMAlessandra Mambrin
Alessandra Mambrin
MFMarco Di Fraia
Marco Di Fraia
ETErsilia Tolino
Ersilia Tolino
CPConcetta Potenza
Concetta Potenza
Click on the article title to read more.